# POTS Adrenergic Ab (CIHR Aims #1&2)

> **NCT02673996** · — · RECRUITING · sponsor: **University of Calgary** · enrollment: 125 (estimated)

## Conditions studied

- Postural Tachycardia Syndrome

## Interventions

- **DRUG:** Phenylephrine
- **DRUG:** Isoproterenol

## Key facts

- **NCT ID:** NCT02673996
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2016-01
- **Primary completion:** 2029-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 125 (ESTIMATED)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02673996

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02673996, "POTS Adrenergic Ab (CIHR Aims #1&2)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02673996. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*